Fairmount Funds Management’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,245,929
Closed -$77.5M 17
2023
Q4
$77.5M Buy
1,245,929
+24,025
+2% +$1.49M 8.18% 5
2023
Q3
$27.1M Buy
+1,221,904
New +$27.1M 3.26% 12